Liibüa
Upper-middle income
- Ülevaade
- Rasvumise levimus
- Rahvastiku jaotus
- Tegurid
- Kaasnevad haigused
- Majanduslik mõju
- Strateegiad
- Contextual factors
Info laeb. Palun oodake!
Riiklik rasvumisrisk *8/10This is a composite ‘obesity risk’ score (out of 10, the highest risk) based on obesity prevalence, rate of increase, likelihood of meeting the 2025 target, treatment indicator and childhood stunting levels.Laste rasvumise oht *9/11This is a ‘risk score’ for each country’s likelihood of having or acquiring a major childhood obesity problem during the 2020s, taking account of current prevalence levels and risk for future obesity (based on stunting among infants, maternal obesity, maternal smoking, and breastfeeding rates).
Report cards
Our report cards collate all the most-recent graphics for this country. If you would like to produce a custom report based on selected graphics, just tap the Add to custom PDF button below the graphics you would like to use.
Tegurid
Kaasnevad haigused
Majanduslik mõju
Contextual factors
Rasvumise levimus
Täiskasvanud, 2015
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 20-65 |
| Valimi suurus: | 401 |
| Hõlmatud piirkond: | Benghazi |
| Viited: | Prevalence of Overweight and Obesity among Libyan Men and Women. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662481/ (last accessed 05.06.2022) |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Täiskasvanud, 2009
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 25-64 |
| Valimi suurus: | 3229 |
| Hõlmatud piirkond: | Riiklik |
| Viited: | WHO STEPS Libyan Arab Jamahiriya Report |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Lapsed, 2013-2014
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 15-18 |
| Valimi suurus: | 307 |
| Hõlmatud piirkond: | Piirkondlik |
| Viited: | Musaiger A.O et al. 2016. Prevalence of overweight and obesity among adolescents in eight Arab countries: comparison between two international standards (ARABEAT-2). Nutr Hosp. 33(5). pp. 1062-1065. |
| Märkused: | Region: Tripoli, Note: Small sample size, n=307 |
| Cutoffs: | IOTF |
Lapsed, 2010-2011
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 15-18 |
| Valimi suurus: | 429 |
| Hõlmatud piirkond: | Linna |
| Viited: | Musaiger AO, Al-Mannai M, Tayyem R, Al-Lalla O, Ali EY, Kalam F, Benhamed MM, Saghir S, Halahleh I, Djoudi Z, Chirane M.Prevalence of Overweight and Obesity among Adolescents in Seven Arab Countries: A Cross-Cultural Study. J Obes. 2012;2012:981390. doi: 10.1155/2012/981390. Epub 2012 Sep 18. |
| Cutoffs: | IOTF |
Lapsed, 2007
| Uuringu tüüp: | Ise teatatud |
| Vanus: | 13-15 |
| Valimi suurus: | 2242 |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Libya - Global School-Based Student Health Survey 2007 https://www.who.int/ncds/surveillance/gshs/libya/en/ (Last accessed 20.10.2020) |
| Cutoffs: | WHO |
0-5 years, 2014
| Vanus: | 0-5 |
| Valimi suurus: | 9876 |
| Viited: | PAPFAM: Libya 2014 National Family Health Survey |
| Märkused: | UNICEF/WHO/World Bank Joint Child Malnutrition Estimates Expanded Database: Overweight (Survey Estimates), May 2023, New York. For more information about the methodology, please consult https://data.unicef.org/resources/jme-2023-country-consultations/ Percentage of children under 5 years of age falling above 2 standard deviations (moderate and severe) from the median weight-for-height of the reference population. |
| Mõisted: | =>+2SD |
0-5 years, 2007
| Vanus: | 0-5 |
| Valimi suurus: | 10723 |
| Viited: | PAPFAM: National Libyan family health survey. PAPFAM surveys. Cairo: The league of Arab States, 2008 |
| Märkused: | UNICEF/WHO/World Bank Joint Child Malnutrition Estimates Expanded Database: Overweight (Survey Estimates), May 2023, New York. For more information about the methodology, please consult https://data.unicef.org/resources/jme-2023-country-consultations/ Percentage of children under 5 years of age falling above 2 standard deviations (moderate and severe) from the median weight-for-height of the reference population. |
| Mõisted: | =>+2SD |
0-5 years, 1995
| Vanus: | 0-5 |
| Valimi suurus: | 4452 |
| Viited: | PAPFAM: Libyan maternal and child health survey. PAPCHILD Surveys. Cairo: The League of Arab States, 1997 |
| Märkused: | UNICEF/WHO/World Bank Joint Child Malnutrition Estimates Expanded Database: Overweight (Survey Estimates), May 2023, New York. For more information about the methodology, please consult https://data.unicef.org/resources/jme-2023-country-consultations/ Percentage of children under 5 years of age falling above 2 standard deviations (moderate and severe) from the median weight-for-height of the reference population. |
| Mõisted: | =>+2SD |
Ülekaalulisus / rasvumine vanuse järgi
Täiskasvanud, 2015
| Uuringu tüüp: | Mõõdetud |
| Valimi suurus: | 401 |
| Hõlmatud piirkond: | Benghazi |
| Viited: | Prevalence of Overweight and Obesity among Libyan Men and Women. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662481/ (last accessed 05.06.2022) |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Ülekaalulisus / rasvumine piirkonna järgi
0-5 years, 1995
| Valimi suurus: | 4452 |
| Viited: | PAPFAM: Libyan maternal and child health survey. PAPCHILD Surveys. Cairo: The League of Arab States, 1997 |
| Märkused: | UNICEF/WHO/World Bank Joint Child Malnutrition Estimates Expanded Database: Overweight (Survey Estimates), May 2023, New York. For more information about the methodology, please consult https://data.unicef.org/resources/jme-2023-country-consultations/ Percentage of children under 5 years of age falling above 2 standard deviations (moderate and severe) from the median weight-for-height of the reference population. |
| Mõisted: | =>+2SD |
Ülekaalulisus / rasvumine sotsiaalmajandusliku grupi järgi
0-5 years, 2014
| Valimi suurus: | 9876 |
| Viited: | PAPFAM: Libya 2014 National Family Health Survey |
| Märkused: | UNICEF/WHO/World Bank Joint Child Malnutrition Estimates Expanded Database: Overweight (Survey Estimates), May 2023, New York. For more information about the methodology, please consult https://data.unicef.org/resources/jme-2023-country-consultations/ Percentage of children under 5 years of age falling above 2 standard deviations (moderate and severe) from the median weight-for-height of the reference population. |
| Mõisted: | =>+2SD |
Double burden of underweight & overweight
Täiskasvanud, 2022
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 20+ |
| Viited: | NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2. |
| Märkused: | Age Standardised estimates |
| Mõisted: | Combined prevalence of BMI<18.5 kg/m² and BMI>=30 kg/m² (double burden of underweight and obesity) |
Lapsed, 2022
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 5-19 |
| Viited: | NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2. |
| Märkused: | Age standardised estimates |
| Mõisted: | Combined prevalence of BMI < -2SD and BMI > 2SD (double burden of thinness and obesity) |
| Cutoffs: | BMI < -2SD and BMI > 2SD |
0-5 years, 1995-1995
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 0-5 |
| Viited: | UNICEF data available at https://data.unicef.org/topic/nutrition/malnutrition/(last accessed 12.03.25) |
| Märkused: | Children under 5 falling below -2 standard deviations from the median height for age and falling at or above +2 standard deviations from the median weight-for-height of the reference population |
Ebapiisav füüsiline aktiivsus
Täiskasvanud, 2022
| Uuringu tüüp: | Ise teatatud |
| Vanus: | 18+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-) |
| Mõisted: | Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent. |
Mehed, 2022
| Uuringu tüüp: | Ise teatatud |
| Vanus: | 18+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-) |
| Mõisted: | Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent. |
Naised, 2022
| Uuringu tüüp: | Ise teatatud |
| Vanus: | 18+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-) |
| Mõisted: | Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent. |
Täiskasvanud, 2016
| Viited: | Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet 2018 http://dx.doi.org/10.1016/S2214-109X(18)30357-7 |
Mehed, 2016
| Viited: | Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet 2018 http://dx.doi.org/10.1016/S2214-109X(18)30357-7 |
Naised, 2016
| Viited: | Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet 2018 http://dx.doi.org/10.1016/S2214-109X(18)30357-7 |
Lapsed, 2016
| Uuringu tüüp: | Ise teatatud |
| Vanus: | 11-17 |
| Viited: | Global Health Observatory data repository, World Health Organisation, https://apps.who.int/gho/data/node.main.A893ADO?lang=en (last accessed 16.03.21) |
| Märkused: | % of school going adolescents not meeting WHO recommendations on Physical Activity for Health, i.e. doing less than 60 minutes of moderate- to vigorous-intensity physical activity daily. |
| Mõisted: | % Adolescents insufficiently active (age standardised estimate) |
Poisid, 2016
| Uuringu tüüp: | Ise teatatud |
| Vanus: | 11-17 |
| Viited: | Global Health Observatory data repository, World Health Organisation, https://apps.who.int/gho/data/node.main.A893ADO?lang=en (last accessed 16.03.21) |
| Märkused: | % of school going adolescents not meeting WHO recommendations on Physical Activity for Health, i.e. doing less than 60 minutes of moderate- to vigorous-intensity physical activity daily. |
| Mõisted: | % Adolescents insufficiently active (age standardised estimate) |
Tüdrukud, 2016
| Uuringu tüüp: | Ise teatatud |
| Vanus: | 11-17 |
| Viited: | Global Health Observatory data repository, World Health Organisation, https://apps.who.int/gho/data/node.main.A893ADO?lang=en (last accessed 16.03.21) |
| Märkused: | % of school going adolescents not meeting WHO recommendations on Physical Activity for Health, i.e. doing less than 60 minutes of moderate- to vigorous-intensity physical activity daily. |
| Mõisted: | % Adolescents insufficiently active (age standardised estimate) |
Lapsed, 2010
| Vanus: | 11-17 |
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A893?lang=en |
| Märkused: | % of school going adolescents not meeting WHO recommendations on Physical Activity for Health, i.e. doing less than 60 minutes of moderate- to vigorous-intensity physical activity daily. |
| Mõisted: | % Adolescents insufficiently active (age standardised estimate) |
Poisid, 2010
| Vanus: | 11-17 |
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A893?lang=en |
| Märkused: | % of school going adolescents not meeting WHO recommendations on Physical Activity for Health, i.e. doing less than 60 minutes of moderate- to vigorous-intensity physical activity daily. |
| Mõisted: | % Adolescents insufficiently active (age standardised estimate) |
Tüdrukud, 2010
| Vanus: | 11-17 |
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A893?lang=en |
| Märkused: | % of school going adolescents not meeting WHO recommendations on Physical Activity for Health, i.e. doing less than 60 minutes of moderate- to vigorous-intensity physical activity daily. |
| Mõisted: | % Adolescents insufficiently active (age standardised estimate) |
Estimated per capita fruit intake
Täiskasvanud, 2017
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 25+ |
| Viited: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| Mõisted: | Estimated per-capita fruit intake (g/day) |
Hinnanguline töödeldud liha tarbimine inimese kohta
Täiskasvanud, 2017
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 25+ |
| Viited: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| Mõisted: | Estimated per-capita processed meat intake (g per day) |
Estimated per capita whole grains intake
Täiskasvanud, 2017
| Uuringu tüüp: | Mõõdetud |
| Vanus: | 25+ |
| Viited: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| Mõisted: | Estimated per-capita whole grains intake (g/day) |
Vaimne tervis - depressiivsed häired
Täiskasvanud, 2021
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| Mõisted: | Number living with depression per 100,000 population (adults 20+ years) |
Mehed, 2021
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| Mõisted: | Number living with depression per 100,000 population (adults 20+ years) |
Naised, 2021
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| Mõisted: | Number living with depression per 100,000 population (adults 20+ years) |
Täiskasvanud, 2015-2021
| Viited: | Prevalence data from Global Burden of Disease study 2015 (http://ghdx.healthdata.org) published in: Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. |
| Mõisted: | % of population with depression disorders |
Täiskasvanud, 2015-2021
| Viited: | Prevalence data from Global Burden of Disease study 2015 (http://ghdx.healthdata.org) published in: Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. |
| Mõisted: | % of population with depression disorders |
Mehed, 2015-2021
| Viited: | Prevalence data from Global Burden of Disease study 2015 (http://ghdx.healthdata.org) published in: Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. |
| Mõisted: | % of population with depression disorders |
Naised, 2015-2021
| Viited: | Prevalence data from Global Burden of Disease study 2015 (http://ghdx.healthdata.org) published in: Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. |
| Mõisted: | % of population with depression disorders |
Lapsed, 2021
| Hõlmatud piirkond: | Riiklik |
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| Mõisted: | Number living with depressive disorder per 100,000 population (Under 20 years of age) |
Poisid, 2021
| Hõlmatud piirkond: | Riiklik |
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| Mõisted: | Number living with depressive disorder per 100,000 population (Under 20 years of age) |
Tüdrukud, 2021
| Hõlmatud piirkond: | Riiklik |
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| Mõisted: | Number living with depressive disorder per 100,000 population (Under 20 years of age) |
Vaimne tervis - ärevushäired
Täiskasvanud, 2021
| Vanus: | 20+ |
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25). |
| Mõisted: | Number living with anxiety per 100,000 population |
Mehed, 2021
| Vanus: | 20+ |
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25). |
| Mõisted: | Number living with anxiety per 100,000 population |
Naised, 2021
| Vanus: | 20+ |
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25). |
| Mõisted: | Number living with anxiety per 100,000 population |
Täiskasvanud, 2015-2021
| Viited: | Prevalence data from Global Burden of Disease study 2015 (http://ghdx.healthdata.org) published in: Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. |
| Mõisted: | % of population with anxiety disorders |
Täiskasvanud, 2015-2021
| Viited: | Prevalence data from Global Burden of Disease study 2015 (http://ghdx.healthdata.org) published in: Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. |
| Mõisted: | % of population with anxiety disorders |
Mehed, 2015-2021
| Viited: | Prevalence data from Global Burden of Disease study 2015 (http://ghdx.healthdata.org) published in: Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. |
| Mõisted: | % of population with anxiety disorders |
Naised, 2015-2021
| Viited: | Prevalence data from Global Burden of Disease study 2015 (http://ghdx.healthdata.org) published in: Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. |
| Mõisted: | % of population with anxiety disorders |
Lapsed, 2021
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
Poisid, 2021
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
Tüdrukud, 2021
| Viited: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
Söögitoruvähk
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Indicence per 100,000 |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Indicence per 100,000 |
Mehed, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Rinnavähk
Naised, 2022
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Pärasoolevähk
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Mehed, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Kõhunäärmevähk
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Mehed, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Sapipõie vähk
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Indicence per 100,000 |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Indicence per 100,000 |
Mehed, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Neeruvähk
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Mehed, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Naised, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Emakavähk
Naised, 2022
| Vanus: | 20+ |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Naised, 2020-2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2221 |
| Mõisted: | Age-standardized indicence rates per 100 000 |
Kõrgenenud vererõhk
Täiskasvanud, 2015
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A875?lang=en |
| Mõisted: | Age Standardised estimated % Raised blood pressure 2015 (SBP>=140 OR DBP>=90). |
Mehed, 2015
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A875?lang=en |
| Mõisted: | Age Standardised estimated % Raised blood pressure 2015 (SBP>=140 OR DBP>=90). |
Naised, 2015
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A875?lang=en |
| Mõisted: | Age Standardised estimated % Raised blood pressure 2015 (SBP>=140 OR DBP>=90). |
Kõrgenenud kolesteroolitase
Täiskasvanud, 2008
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A885 |
| Mõisted: | % Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate). |
Mehed, 2008
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A885 |
| Mõisted: | % Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate). |
Naised, 2008
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A885 |
| Mõisted: | % Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate). |
Kõrgenenud veresuhkru tase tühja kõhuga
Mehed, 2014
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A869?lang=en |
| Mõisted: | Age Standardised % raised fasting blood glucose (>= 7.0 mmol/L or on medication). |
Naised, 2014
| Viited: | Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A869?lang=en |
| Mõisted: | Age Standardised % raised fasting blood glucose (>= 7.0 mmol/L or on medication). |
Diabeedi levimus
Täiskasvanud, 2024
| Viited: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium:International Diabetes Federation, 2025. http://www.diabetesatlas.org |
Täiskasvanud, 2021
| Vanus: | 20-79 |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium:International Diabetes Federation, 2021. http://www.diabetesatlas.org |
| Mõisted: | Age-adjusted comparative prevalence of diabetes, % |
Täiskasvanud, 2019
| Vanus: | 20-79 |
| Viited: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels,Belgium: 2019. Available at: https://www.diabetesatlas.org |
| Mõisted: | Diabetes age-adjusted comparative prevalence (%). |
Täiskasvanud, 2017
| Viited: | Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org |
| Mõisted: | Diabetes age-adjusted comparative prevalence (%). |
Ovarian Cancer
Naised, 2022
| Vanus: | 20+ |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Leukemia
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Leukemia
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Liver and intrahepatic bile duct Cancer
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Multiple Myeloma
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Indicence per 100,000 |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Indicence per 100,000 |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Non Hodgkin Lymphoma
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
| Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m². | |
Thyroid Cancer
Mehed, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Naised, 2022
| Vanus: | 20+ |
| Hõlmatud piirkond: | Riiklik |
| Viited: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| Mõisted: | Incidence per 100,000 |
Economic impact of overweight and obesity
Policies, Interventions and Actions
Contextual factors
Disclaimer: These contextual factors should be interpreted with care. Results are updated as regularly as possible and use very specific criteria. The criteria used and full definitions are available for download at the bottom of this page.
Tap on a tick to find out more about policies influencing this factor.
Labelling
| Is there mandatory nutrition labelling? | Absent |
| Front-of-package labelling? | Absent |
| Back-of-pack nutrition declaration? | Absent |
| Color coding? | Absent |
| Warning label? | Absent |
Regulation and marketing
| Are there fiscal policies on unhealthy products? | Absent |
| Tax on unhealthy foods? | Absent |
| Tax on unhealthy drinks? | Absent |
| Are there fiscal policies on healthy products? | Absent |
| Subsidy on fruits? | Absent |
| Subsidy on vegetables? | Absent |
| Subsidy on other healthy products? | Absent |
| Mandatory limit or ban of trans fat (all settings)? | Absent |
| Mandatory limit of trans fats in place (all settings)? | Absent |
| Ban on trans-fats or phos in place (all settings)? | Absent |
| Are there any mandatory policies/marketing restrictions on the promotion of unhealthy food/drinks to children? | Absent |
| Mandatory restriction on broadcast media? | Absent |
| Mandatory restriction on non-broadcast media? | Absent |
| Voluntary policies/marketing restrictions on the promotion of unhealthy food/drinks to children? | Absent |
| Are there mandatory standards for food in schools? | Absent |
| Are there any mandatory nutrient limits in any manufactured food products? | Absent |
| Nutrition standards for public sector procurement? | Absent |
Political will and support
| National obesity strategy or nutrition and physical activity national strategy? | Absent |
| National obesity strategy? | Absent |
| National childhood obesity strategy? | Absent |
| Comprehensive nutrition strategy? | Absent |
| Comprehensive physical activity strategy? | Absent |
| Evidence-based dietary guidelines and/or RDAs? | Absent |
| National target(s) on reducing obesity? | Absent |
| Promotion of breastfeeding? | Unknown |
Monitoring and surveillance
| Monitoring of the prevalence and incidence for the main obesity-related NCDs and risk factors? | Present |
| Within 5 years? | Absent |
Governance and resource
| Multi-sectoral national co-ordination mechanism for obesity or nutrition (including obesity)? | Absent |
Key
Present
Present (voluntary)
Incoming
Absent
Unknown
Last updated September 13, 2022
Download contextual factors as a PDF Contextual factors definitions
